Azelnidipine NEW
| Price | $44 | $62 | $111 |
| Package | 5mg | 10mg | 25mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: Azelnidipine | CAS No.: 123524-52-7 |
| Purity: 99.83% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | Azelnidipine |
| Description | Azelnidipine (UR-12592) is a dihydropyridine used as calcium channel blocker. |
| In vivo | Studies indicate that Azelnidipine, as a new-generation calcium channel blocker, can treat hypertension regardless of the patient's risk for ischemic heart disease. This novel, long-acting calcium channel blocker exhibits unique pharmacological properties, such as a slower heart rate and high affinity for vascular tissue, distinguishing it from other calcium channel blockers. Additionally, the high lipophilicity of Azelnidipine allows it to remain active in the vascular wall even after being cleared from the bloodstream. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O : < 1 mg/mL (insoluble or slightly soluble) 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (17.16 mM), Solution. Ethanol : 7 mg/mL (12.01 mM), Sonication is recommended. DMSO : 250 mg/mL (429.07 mM), Sonication is recommended. 10% DMSO+90% Saline : < 10 mg/mL (17.16 mM), Lower concentrations may be soluble, but exact solubility limit is unknown. |
| Keywords | UR12592 | UR 12592 | Inhibitor | inhibit | CS-905 | CS905 | CalciumChannel | Calcium Channel | Ca2+ channels | Ca channels | Azelnidipine |
| Inhibitors Related | Quadrol | Tricaine methanesulfonate | Nisoldipine | 2,4,6-Tri-tert-butylphenol | Chlorocresol | L-Ascorbic acid | L-Phenylalanine | L-Ascorbic acid sodium salt | 2-Nitrobenzoic acid | Magnesium Chloride Hexahydrate | Magnesium sulfate | Cinchonine |
| Related Compound Libraries | Bioactive Compound Library | Pain-Related Compound Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Neuroprotective Compound Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Ion Channel Targeted Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $44.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-06-02 | |
| $44.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-06-02 | |
| $10.00 |
Hebei Chuanghai Biotechnology Co., Ltd
|
2026-03-20 | ||
| $30.00 |
Henan Bao Enluo International TradeCo.，LTD
|
2023-08-02 | ||
| $10.00 |
Hebei Zhanyao Biotechnology Co. Ltd
|
2021-11-02 | ||
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-13 | ||
|
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2020-05-09 | ||
| $1.00 |
VIP8Y
|
Career Henan Chemical Co
|
2019-07-06 | |
| $46.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-05-02 | |
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-09 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY